Galα(1,3)Gal Epitope in Porcine Small Intestinal Submucosa

Small intestinal submucosa (SIS) is a naturally occurring, acellular biomaterial derived from porcine jejunum, which promotes constructive tissue remodeling when applied as a xenogeneic graft mater...

[1]  C. Basbaum,et al.  Identification of erythrocyte Gal alpha 1-3Gal glycosphingolipids with a mouse monoclonal antibody, Gal-13. , 1987, The Journal of biological chemistry.

[2]  S. Badylak,et al.  The use of xenogeneic small intestinal submucosa as a biomaterial for Achilles tendon repair in a dog model. , 1995, Journal of biomedical materials research.

[3]  S. Badylak,et al.  Small Intestinal Submucosa: Utilization as a Wound Dressing in Full‐Thickness Rodent Wounds , 1995, Annals of plastic surgery.

[4]  U. Galili,et al.  Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Badylak,et al.  Small intestinal submucosa: a rapidly resorbed bioscaffold for augmentation cystoplasty in a dog model. , 1998, Tissue engineering.

[6]  S. Badylak,et al.  Histologic findings after in vivo placement of small intestine submucosal vascular grafts and saphenous vein grafts in the carotid artery in dogs. , 1992, The American journal of pathology.

[7]  U. Galili,et al.  Distribution of Gal.alpha.1.fwdarw.3Gal.beta.1.fwdarw.4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay , 1990 .

[8]  S. Badylak,et al.  Biocompatibility of small-intestinal submucosa in urinary tract as augmentation cystoplasty graft and injectable suspension. , 1994, Journal of endourology.

[9]  J. Griffiss,et al.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. , 1992, The Journal of clinical investigation.

[10]  S. Badylak,et al.  Identification of extractable growth factors from small intestinal submucosa , 1997, Journal of cellular biochemistry.

[11]  M. Sandrin,et al.  Galα(1,3)Gal, the Major Xenoantigen(s) Recognised in Pigs by Human Natural Antibodies , 1994, Immunological reviews.

[12]  S. Shohet,et al.  Human natural anti-alpha-galactosyl IgG. II. The specific recognition of alpha (1----3)-linked galactose residues , 1985, The Journal of experimental medicine.

[13]  R C Harruff,et al.  Experimental assessment of small intestinal submucosa as a bladder wall substitute. , 1995, Urology.

[14]  D. Cooper,et al.  Heterogeneity of preformed human antipig xenogeneic antibodies. , 1992, Transplantation proceedings.

[15]  E. Jabs,et al.  Characterization of an alpha 1----3-galactosyltransferase homologue on human chromosome 12 that is organized as a processed pseudogene. , 1991, The Journal of biological chemistry.

[16]  S. Badylak,et al.  Histology after dural grafting with small intestinal submucosa. , 1996, Surgical neurology.

[17]  U. Galili.  Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation in humans. , 1993, Immunology today.

[18]  D. Cooper.  Xenotransplantation--state of the art. , 1996, Frontiers in bioscience : a journal and virtual library.

[19]  R. Spiro,et al.  Occurrence of alpha-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. , 1984, The Journal of biological chemistry.

[20]  L A Geddes,et al.  Small intestinal submucosa as a large diameter vascular graft in the dog. , 1989, The Journal of surgical research.

[21]  S. Shohet,et al.  Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. , 1988, The Journal of biological chemistry.

[22]  U. Galili,et al.  A unique natural human IgG antibody with anti-alpha-galactosyl specificity , 1984, The Journal of experimental medicine.

[23]  T. Cook,et al.  Inhibition of the human antipig xenograft reaction with soluble oligosaccharides. , 1995, Transplantation proceedings.

[24]  A. Gabrielli,et al.  Antibodies to mouse laminin in patients with systemic sclerosis (scleroderma) recognize galactosyl (αl‐3)‐galactose epitopes , 1991, Clinical and experimental immunology.

[25]  M. Neuberger,et al.  Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies , 1987, The Journal of experimental medicine.

[26]  R. Timpl,et al.  Circulating antibodies to mouse laminin in Chagas disease, American cutaneous leishmaniasis, and normal individuals recognize terminal galactosyl(alpha 1-3)-galactose epitopes , 1987, The Journal of experimental medicine.

[27]  I. Sandlie,et al.  Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region. , 1992, Molecular immunology.

[28]  J. Platt,et al.  Modulation of natural IgM binding and complement activation by natural IgG antibodies: a role for IgG anti-Gal alpha1-3Gal antibodies. , 1996, Journal of immunology.

[29]  L A Geddes,et al.  Mechanical properties of xenogeneic small-intestinal submucosa when used as an aortic graft in the dog. , 1995, Journal of biomedical materials research.